MINNEAPOLIS–(BUSINESS WIRE)–Humanetics Corporation (Humanetics), an advanced clinical-stage specialty pharmaceutical company, is pleased to announce the appointment of Timothy E. Morris as its new Chief Operating Officer (COO). Humanetics is a leading innovator in radiation medical countermeasure development, also pioneering novel approaches to normal tissue protection in oncology-related radiation therapy and mitigating the inflammatory response in pulmonary diseases. In his new capacity at